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Selective counting and sizing of single virus particles using 
fluorescent aptamer-based nanoparticle tracking analysis 
Zoltán Szakácsa, Tamás Mészárosb, Marien I. de Jongec, Róbert E. Gyurcsányia* 
Detection and counting of single virus particle in liquid samples is largely limited to narrow size distribution viruses and 
purified formulations. To address these limitations here we propose a calibration-free method that enables concurrently 
the selective recognition, counting and sizing of virus particles as demonstrated through the detection of human respiratory 
syncytial virus (RSV), an enveloped virus with broad size distribution, in throat swab samples. RSV viruses were selectively 
labeled through their attachment glycoproteins (G) with fluorescent aptamers, which further enabled their identification, 
sizing and counting at single particle level by fluorescent nanoparticle tracking analysis. The proposed approach seems to be 
generally applicable to virus detection and quantification. Moreover, it could be successfully applied to detect single RSV 
particles in diluted throat swab samples of diagnostic relevance. Since the selective recognition is associated with the sizing 
of each detected particle the method enables to discriminate between viral elements linked to the virus as well as between 
various virus forms and associations. 
Introduction 
Viruses can be detected either directly or indirectly through the 
host immune response (e.g. detection of virus-specific 
antibodies generated in response to the infection).1 Direct 
detection certainly prevail to characterize and standardize virus 
preparations, but are also used for medical diagnostics because 
it enables genotyping and is more specific than the 
measurement of host immune responses, e.g. are not restricted 
by seroconversion times, co-morbidities or treatments.1 
However, the majority of direct detection methodologies target 
only a single component of the virus, i.e., characteristic nucleic 
acids and proteins even though virus pathogenesis involves 
whole virus particles.2 Therefore, the interpretation of the 
results may be complicated if the detected viral elements are 
not linked to intact viral particles but originate from 
disintegrated viruses or contaminations. A major step in 
discriminating between the free and virus integrated proteins 
was made by introducing a dedicated flow cytometry 
technique3 based on the concomitant detection of stained viral 
proteins and nucleic acids, which increases the likelihood of 
detecting viral components integrated in virus particles. 
However, in this respect the most comforting would be if the 
selective detection of particular virus components is associated 
with the size of the measured entity as well. Virus sizing in the 
submicron range has been demonstrated with a wide range of 
techniques including electron microscopy,4 atomic force 
microscopy,5 various light scattering6, 7 and interferometric 
techniques,8 nanoparticle tracking analysis9, 10 and resistive 
pulse sensing.11-13 These techniques if used self-standing are 
able to size and in some cases even count viruses in properly 
purified samples such as vaccines, but even their excellent size 
resolution may not be sufficient to unambiguously identify and 
quantify viruses in complex biological samples. Therefore, 
attempts have been made to combine high resolution sizing 
with specific detection of a viral component mainly by 
antibodies raised against viral coat proteins to selectively detect 
virus particles. Techniques capable to detect and count single 
virus particles in liquids were realized both in heterogeneous 
and homogeneous formats. Thus surface-immobilized 
antibodies could be used to capture viruses in predefined spots 
to be consecutively revealed by AFM imaging5. Alternatively, 
antibodies were added to the sample to selectively increase the 
size of the viruses that could be detected by resistive pulse 
sensing.14 However, despite the maturity of single virus 
detection methodologies these are still largely limited to 
purified virus formulations. Moreover, detection methods that 
are relying, at least partially, on the size of the particles are 
mostly targeting viruses of well-defined size and difficulties are 
foreseen if applied for viruses that feature an inherently broad 
size distribution. Therefore, we were interested to address 
these limitations by developing a fluorescent nanoparticle 
tracking analysis methodology that enables the selective 
detection and counting of single viruses with broad size 
distribution. 
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Scheme 1. Schematic of the selective virus sizing and counting by fluorescent 
nanoparticle tracking. The RSV containing sample incubated with fluorescently 
labeled aptamer is flown through the thin layer cell illuminated by a 488 nm laser 
beam.  Using a cut-off filter of 495 nm the scattered light is removed and solely 
the fluorescently labeled virus particles are tracked (red lines). The speed of their 
motion provides the equivalent diameter of the viruses while the virus count is 
given by the average number of virus particles detected in the sensing volume.  
 
Nanoparticle tracking analysis (NTA) was introduced as a 
general method to size and count biological and synthetic 
nanoparticles in solutions by taking advantage of their light 
scattering properties.15-17 The motion of individual 
nanoparticles is tracked to provide their diffusion coefficient 
that is further used to calculate their size by Stokes-Einstein 
equation. Furthermore, nanoparticles can be tracked also by 
their fluorescence if adequate wavelength excitation lasers and 
emission filters are applied. Considering this possibility, we 
hypothesized that adding fluorescently labeled receptors, 
selective for a surface exposed viral protein, the fluorescent 
receptor concentration will locally increase around the virus in 
a sufficient extent to enable its differentiation from the 
fluorescent background. Accordingly, the virus particles can be 
identified as fluorescent particles, sized and quantified (Scheme 
1). Accordingly, the virus particles can be identified as 
fluorescent particles, sized and quantified (Scheme 1). 
Currently, there is strong interest for synthetic receptors for 
viruses as alternatives to antibodies1, 18 due to their better 
stability and versatility in terms of custom chemical 
modification. Therefore, for the fluorescent detection of virus 
particles we took advantage of monovalent fluorescently 
labeled aptamers to rule out virus aggregation. For proof of 
concept we used respiratory syncytial virus A2 (RSV), an 
enveloped virus that shows not only a very broad size 
distribution (ca. 100 -1000 nm)19 but also variation in shape that 
includes spherical and filamentous particles.20 RSV is one of the 
most common pathogens to cause lower respiratory tract 
infections that affects all age groups but most severely children 
younger than 2 years of age as well as elderly and 
immunocompromised patients. These patients may develop 
complications and it was estimated that RSV is responsible for 
up to 35% of pneumonia cases.21 Given the high diagnostic 
relevance of RSV detection22 we explored the application of the 
single virus detection methodology in throat swab-based 
samples. 
 
Experimental section 
Chemicals and reagents 
DNA aptamers labelled with Alexa Fluor 488 at their 5'-ends 
were custom synthetized by Sigma-Aldrich and formulated as 
100 µM solutions in pH=8.0 Tris-EDTA buffer. The variable 30-
mer nucleotide regions of the RSV aptamers were flanked by 
two constant (16-mer) sequences 5′ -TAG GGA AG AGA AGG 
ACA TAT GAT-30 N- TTGACTAGTACATGACCACTTGA-3′ (TCC ATA 
TCG TTT AGC GTA CGG TGG CAG TCT (B10) ; ACC CGT CGG ACT 
CGG CCA TAA ATT AAA GGC (E6); GTG TCC GTT CTT ATT GGC 
GGC TCC CAA TGT (E10), TCA TTA GGT GAG TGT CCG TTC TAC 
ACT ATA (E11); AGT GCG GTG  AGC CGT CGG ACA TAC AAA TAC 
(H8)). As control a random 76-mer DNA sequence (randomDNA) 
was used (5’ –ATC CAG AGT GAC GCA GCA TAT TTC GAC CTT CTA 
CCT TTG ATT TTT GTG GTC CTC AGT GTG GAC ACG GTG GCT TAG 
T- 3’).  All solutions were prepared or diluted with a pH=7.4 
phosphate buffered saline (PBS, P4417, Sigma-Aldrich). To 
prepare solutions for the NTA experiments the PBS was filtered 
through 50 nm pore diameter polycarbonate membranes 
(Osmonics Inc.). FITC labelled anti-respiratory syncytial virus 
polyclonal antibody (FITC-antiRSV, ab156657) and FITC-labeled 
anti-nucleoprotein (FITC-ab25849) was purchased from Abcam. 
Human rhinovirus (HRV) was kindly provided by Kjerstin Lanke 
(Department of Medical Microbiology, Radboud Medical 
University). 
 
RSV culturing and formulation 
For RSV cultivation RSV A2 infected HeLa cells were used as 
described in detail previously.23 The extraction and purification 
of the RSV followed a previously reported standard 
procedure.23, 24 In brief, the cell suspension was subjected to a 
first centrifugation step of 1800×g for 10 min to remove the 
rough cell debris, followed by ultracentrifugation over a 30% 
sucrose layer at 72 000×g for 1.5h. Titration on HeLa cells 
followed by a permeabilization and fixation step using Perm/Fix 
buffers (Becton Dickinson). The cells were incubated with FITC-
ab25849 for 30min on ice washed with Perm/Wash buffers 
(Becton Dickinson) and measured on the flow-cytometer (LSR II, 
Becton Dickinson). The concentration of infectious particles 
(plaque forming unit equivalents, PFUe) was determined as the 
number of positive cells per volume. For laboratory use the RSV 
A2 was inactivated by incubation with β-propiolactone (0.025%) 
under continuous slow shaking at 4 °C for 16 h.25 The excess of 
the reagent was left to hydrolyse for 4 h by increasing the 
temperature to 37 °C and the resulted formulation was stored 
at −80 °C. 
 
Throat swab sample collection 
Throat swabs were attained from healthy volunteers with 
medical swab sticks (Meus S.r.L). The swabs were immediately 
soaked in 2 mL PBS (pH=7.4; 1.37 M NaCl, 27 mM KCl, 20 mM 
KH2PO4, 100 mM Na2HPO4), vortexed, and then centrifuged at 
room temperature (19 060xg) for 2 min to transfer the throat 
sample from the swab into the centrifuge tube. The collected 
liquid was stored at -20°C.   
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NTA experiments 
The NTA experiments were performed using a NanoSight LM10-
HS instrument (Malvern) equipped with a 488 nm laser light 
source and a sCMOS camera (Hamamatsu Photonics) triggered 
by the laser. In fluorescence mode a 495 nm cut-off filter was 
used to eliminate the scattered light. Samples of 200-500 l 
were flown through the thin layer cell at 6.5 µL/min flow rate 
using a syringe pump (Harvard Apparatus). The particle tracks 
were recorded and analysed by NanoSight NTA 2.3 software 
package. Of note, the NTA software automatically corrects the 
random particle motion with the unidirectional movement 
generated by the sample flow. The particle concentrations were 
calculated as the average of either at least 5 one-minute 
measurements or at least 50 particle tracks The throat swab 
samples were diluted 10-fold and spiked with various RSV 
concentrations. The samples were further centrifuged at 
2500×g for 15 min to remove large size debris and 800 L 
aliquots were used for each NTA measurement. The different 
RSV samples, both formulated in PBS and in diluted throat swab 
samples, were fluorescently labelled with 25 nM AlexaFluor488-
aptamer conjugates (or 25 nM FITC-antiRSV antibody) and 
subjected to NTA detection in fluorescence mode without 
separation. 
 
 Fluorescence and fluorescence polarization measurements 
The fluorescence emission spectra were measured on a Perkin 
Elmer LS50B luminescence spectrometer. To this end samples 
were introduced in fluorescence microcuvettes (105.251 QS 
Hellma) and excited at 490 nm. A 510 nm cut-off filter was used 
to avoid the detection of scattered light from the throat swab 
samples. Fluorescence polarization (FP) experiments were 
performed using a BioTek Synergy 2 microplate reader 
equipped with a xenon flash lamp and a polarizer set using a 
485/20 nm bandpass filter for excitation, a 528/20 nm bandpass 
filter for emission and 510 nm dichroic mirror. During FP a plane 
polarized light is used to excite the fluorescent aptamers with 
the emitted fluorescent light detected in the same plane (III) and 
a plane perpendicular to it (I⏊). The fluorescent aptamer 
binding to the virus was detected through an increase in the 
fluorescence polarization calculated as 𝐹𝑃 = ( 𝐼|| − 𝐼⏊ ⋅ 𝐺) / ( 𝐼|| +
𝐼⏊ ⋅ 𝐺) , where G is an instrument specific  correction factor that 
was determined according to the instructions of the instrument 
manufacturer by using 1nM fluorescein solution. FP 
experiments were performed in 96 well, flat bottom, black 
microtiter plates (CLS3694, Corning) blocked previously with 
Pierce Protein-Free (TBS) Blocking Buffer (37570, ThermoFisher 
Scientific) for 1 h. The sum of volumes was 60 l and the 
fluorescently labelled aptamer concentration 0.5 nM in each 
well. The FP values were reported as the average of 10 
consecutive measurements after the binding equilibrium was 
reached (up to 1 h), which was confirmed by no change in the 
measured fluorescence intensities. 
 RESULTS AND DISCUSSION 
Selective fluorescent labelling of RSV particles 
Selective fluorescent labelling of RSV can be most 
straightforwardly achieved by using a fluorescent dye 
conjugated to specific receptor which binds to a viral protein on 
the virus envelope. The use of aptamers, beside their 
robustness and easy conjugation with fluorescent dyes was also 
motivated by their monovalency. We expected that this will rule 
out virus aggregation during their selective labelling.  
Furthermore, the ca. an order of magnitude smaller molecular 
weight of the aptamers (ca. 22 kDa) than that of conventional 
antibodies may led to larger surface coverage of virus particles 
and by that providing higher sensitivity in this type of 
application. We have previously selected and reported a large 
batch of aptamers for RSV with H8 aptamer exhibiting the best 
performance in proximity based luminescence assay of RSV.24 
However, as the suitability of aptamers may depend on the 
particular application, we have selected further aptamer 
candidates for this study. Their relative affinity for RSV was 
tested using competitive fluorescence polarization assay in 
which fluorescent aptamer candidates (B4, E6, E10, E11, H8) in 
a constant concentration of 0.5 nM competed for RSV (1.2×105 
PFU/mL) with the unlabelled H8 aptamer. Fluorescence 
polarization is a homogeneous assay, i.e., does not require the 
immobilization of the aptamer and the separation of the free 
and virus bound aptamer. The fluorescence polarization scales 
inversely with the rate at which a fluorescent molecule rotates. 
Therefore, the binding of the aptamers to the large virus 
particles, which decreases significantly their rotational rate, can 
be easily followed through the increased FP.26 The competitive 
FP format imposes further stringency to the binding process 
minimizing non-specific binding. The decrease in the 
fluorescence polarization upon increasing the unlabelled H8 
aptamer concentration indicates the degree of displacement of 
the respective fluorescently labelled aptamers form the RSV, 
i.e., its relative affinity for RSV.   
 
As it can be seen in Fig. 1 aptamers H8 and E10 showed the 
highest relative affinity, followed closely by E6 and E11, with 
Fig. 1 Competitive homogeneous FP experiments performed by keeping the 
concentration of fluorescently labelled aptamers and that of the RSV virus 
constant at 0.5 nM and 1.2×105 PFU/mL, respectively, while varying the 
concentration of the unlabelled H8 aptamer. The curves were normalized with 
the FP value measured in the absence of the competing aptamer (FP0). 
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B10 exhibiting significantly poorer performance. Based on this 
result H8 aptamer was used for most of the follow up 
measurements. 
 Fluorescence polarization experiments were carried out in 
the support of the selective labelling of the RSV virus. Human 
rhinovirus a likely coexisting pathogen in the RSV containing 
swab throat samples was used for this purpose and both virus 
formulations were incubated with the AlexaFluor488-H8 
aptamer. At low virus concentrations (<106 PFU/mL) no 
association with the HRV could be observed while the binding 
to the RSV was detected at almost two orders of magnitude 
lower concentrations (Fig. 2A).    
 
 It is likely that the significant aptamer binding at higher HRV 
concentrations is due to non-specific electrostatic interaction27, 
28 between the negatively charged aptamer and positively 
charged target domains. This is likely to occur as the 
homogeneous FP assay lacks of a stringent washing step that 
would disrupt no-specific interactions. If this scenario applies, 
adding an unlabelled random sequence DNA in sufficiently large 
concentration should displace, by competitive action, the 
aptamer from the HRV. We found that already a 10-fold excess 
(5 nM) random DNA background confirms this hypothesis, i.e. 
no HRV-aptamer complexes could be detected, while the 
fluorescent labelling of RSV was barely affected (Fig. 2B).  
 
 
Sizing and counting of fluorescently labelled RSV particles 
First the RSV virus formulations were investigated in the light 
scattering mode by NTA to assess the total number of particles. 
As expected, we found a rather broad size distribution, from ca. 
40 nm to 1500 nm equivalent diameter (Fig. S1) with a total 
concentration of (2.4±0.19) × 1011 particles/mL (for the stock 
solution).  The largest fraction of the detected particles fallen in 
the 100-200 nm range and tailed towards larger sizes (Fig. S1), 
however, this formulation may still include cell debris and other 
membrane or molecular aggregates. To reveal RSV viruses 
among these by selective fluorescent labelling we used H8 
aptamer that we found earlier to possess the highest affinity to 
attachment glycoprotein (G) of the RSV. 24 The RSV sample (10x 
diluted stock solution) was incubated for 1 h with 625-fold 
excess of the aptamer (25 nM) with respect to the total particle 
concentration and the counting was performed in fluorescence 
mode. To avoid photobleaching the labelled virus formulations 
were flown continuously through the sensing zone to reduce 
their residence in the laser beam. It should be stressed that in 
contrast to the nanoparticle tracking analysis of fluorescent 
particles with “whole volume fluorescence” (e.g. fluorescent 
polymer beads) in our case only the surface of the virus particles 
is fluorescently labelled. The challenge is further increased by 
the fact that after labelling the free fluorescent aptamers are 
not separated from the virus particles. Such a separation-free 
detection clearly ads to the convenience of the method as a 
separation may affect both the size and concentration of the 
virus samples.29 Since the size of the free fluorescent aptamer 
is much smaller than the lower detection limit of NTA in terms 
of size (~40 nm for these type of particles) they cannot be 
detected as separate fluorescent entities, but only as an 
increase in the fluorescent background. In contrast, we 
expected a significantly higher local concentration of the 
fluorescent aptamers binding to the RSV surface than that of 
the free aptamer concentration (Fig. S2 B, C). While accurate 
surface densities of glycoprotein G were not reported if 
considering a 100 nm diameter virus particle and only 100 
aptamers per virus that would amount to a local concentration 
of fluorescent aptamers of ca. 320 nM, which is already more 
than an order of magnitude larger than that of the free aptamer. 
Indeed, while the unlabelled virus gave no fluorescence signal, 
the fluorescently labelled formulation provided clearly 
detectable fluorescent particles, i.e., (5.8±0.15) × 109 
particles/mL (for the stock solution). This count however is 
significantly lower than measured in light scattering mode. To 
rule out that this lower number of fluorescent particles is 
caused by any deficiency of the aptamer binding to the G 
protein or lack of G proteins on some of the viral particles as 
suggested earlier,19 the same experiment was repeated using 
fluorescent polyclonal antibodies specific to all RSV viral 
antigens. The size distribution histograms for both aptamer- 
and polyclonal antibody-based fluorescent labeling of virus 
particles was comfortingly identical (Fig. 3A).  
Fig. 2 Binding of AlexaFluor488-H8 aptamer (0.5 nM) to RSV and HRV in the 
absence (A) and in the presence (B) of randomDNA (10 nM) followed by FP. 
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Owing to the very large heterogeneity of RSV in terms of size 
and packing density of glycoproteins19 it is difficult to estimate 
the number of G-proteins that need to be saturated by the 
fluorescent labeled aptamers. Increasing the aptamer 
concentration for G-protein saturation is not a reasonable 
option because it also elevates the fluorescent background that 
makes the fluorescent RSV particle detection difficult. However, 
by diluting the virus formulation a close to linear relationship 
was obtained between the number of detected virus particles 
and the viral concentration expressed in PFU/mL.  At the highest 
dilution the aptamer is ~3.2×106  -fold excess in respect of the 
virus particles, thus the obtained linear relationship suggest 
that sufficient aptamer is available throughout the studied 
concentration range for the fluorescence visualization of the 
virus particles. The number of polyclonal antibody - and 
aptamer-labeled virus particles was found to be in excellent 
agreement, with the aptamer prevailing in terms of larger linear 
range at higher virus concentrations (Fig. 3B). 
Thus after we ruled out contingent deficiencies of the aptamer 
binding and virus labelling the most likely explanation for the 
much lower particle count in fluorescence than in light 
scattering remains that the RSV preparations even after the 
purification steps contain a large quantity of cell debris. This 
assumption is also supported by the much smaller 
concentration of the infectious particles (PFUe) than the total 
RSV particles given by the fluorescent counting providing a 
particle-to-PFU ratio of 3200. These findings show clearly the 
utility and importance of the selective virus counting 
methodology proposed here in terms of virus standardization 
and characterization.  
 
Detection of RSV in throat swab samples 
To investigate the feasibility of the selective detection of RSV in 
clinically relevant matrices, throat swab samples collected from 
healthy individuals were used. First, it was demonstrated that 
the throat swab sample without the virus spiking does not 
contain any detectable fluorescent particles and does not affect 
the fluorescence of the Alexa488 labelled aptamer (Fig. S3). 
Next the 10-fold diluted throat swab samples were spiked with 
various concentrations of RSV. These samples were incubated 
with H8, B10 and E10 aptamers to investigate the influence of 
their relative affinity on the fluorescent RSV count. The results 
of the fluorescent NTA measurements performed on throat 
swab samples were compared with RSV samples formulated 
solely in PBS (Fig. 4A). We found a close to linear dependence 
between the fluorescent RSV count and the virus concentration 
for both PBS and throat swab samples with an insignificant 
effect of the choice of aptamers on the sensitivity. Although, the 
slope of the response in throat swab samples was ca. 1/3 of that 
of solely PBS-based formulations the result show clearly that 
RSV particles can be detected even in complex throat swab 
samples. 
Fig. 3. (A) Size distribution of RSV viruses detected by NTA in fluorescent mode 
after labelling with fluorescent H8 aptamer and polyclonal RSV antibody. (B) 
NTA determined fluorescent RSV concentrations upon dilution of the RSV 
formulation. 
Fig. 4. Comparison of the fluorescent RSV count (A) and size distributions (B) 
detected after selective fluorescent labelling using different aptamers (25 nM) 
in PBS formulated RSV and 10-fold diluted throat swab samples.  
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Of note, since this method is capable of detecting single RSV 
particles the limit of detection in terms of concentration is in 
fact solely determined by the analysis time, i.e., for smaller 
concentrations larger sample volumes need to be passed 
through the cell, but for this proof of concept study we limited 
the analysis time to max. 20 min.  
There is no change in the size distribution of the RSV viruses 
detected in the two media (Fig. 4B), which rules out contingent 
aggregation or selective loss of a size fraction. Since the throat 
swab sample was found to not affect the fluorescence of the 
aptamers the most likely reason for the lower fluorescence RSV 
count is the competitive displacement of the aptamers by 
constituents of the sample matrix, in particular the DNA 
background present in physiological samples. This assumption 
seems to be confirmed by fluorescence polarization assays in 
which different DNA backgrounds were established using 
salmon sperm DNA and the increasing of the DNA concentration 
led to decreasing FP values, i.e., removal of the fluorescent 
aptamers from RSV (Fig. S4). The lower number of aptamers 
that bind to a virus particle as result of competitive action of the 
sample matrix may reduce the number of detectable RSV 
particles, which could explain the sensitivity discrepancy of RSV 
determination in “pure” formulations and throat swab sample. 
However, even at DNA concentrations as high as 4 µg/mL the 
aptamer could not be fully displaced from the RSV indicating 
clinical applicability of the presented method.  
In terms of virus counting the matrix effect of the throat 
swab samples clearly results in a negative bias. Therefore, while 
fluorescent nanoparticle tracking analysis is an absolute 
method and requires no calibration standards its direct use for 
such sample matrices makes the quantitation of RSV to be 
associated with a high uncertainty. This problem can be 
circumvented if the matrix effect on the RSV count is 
determined by standard addition, i.e., after the fluorescent RSV 
count is determined in the throat swab sample, the sample is 
spiked with RSV standards of known concentration. The ratio of 
the detected and nominal concentration of the RSV standard 
can be used as a correction factor to adjust the RSV 
concentration determined in throat swab samples. Given the 
variability of the throat swab samples among individuals this 
procedure is best to be applied for each individual throat swab 
sample. Table 1. demonstrates that using this standard addition 
technique the error in the quantification of RSV in throat swab 
samples can be reduced to ca. 25 %. 
 
Table 1. Determination of virus counts in throat swab sampled 
with standard addition. The RSV particles were labelled with 
fluorescent H8 aptamer (25 nM) by incubation for 1 h. 
 
RSV count (particle/mL) 
Recovery (%) 
Spiked Measured 
5.53 × 107 5.74 × 107 (± 5.62×106) 103.8 
8.43 × 107 6.37× 107 (± 7.84 ×106) 75.6 
 
Conclusions 
In summary, here we show that single RSV particle detection is 
feasible by fluorescent nanoparticle tracking analysis following 
their selective labelling with fluorescent aptamers. Given the 
size discrimination capability of the method, the detection of 
fluorescently labelled RSV could be achieved even without 
separating the labelled virus from the free fluorescent aptamer.  
Thus this calibration-free counting and sizing method with little 
sample preparation is expected to be very appealing for 
virologist in terms of virus standardization. Moreover, given the 
single species detection ability of the proposed methodology, 
the selective detection of RSV was straightforward even in 
clinically relevant complex samples, such as diluted throat swab 
samples. However, the quantification in case of throat swab 
samples is complicated by a matrix effect (most likely a 
competitive effect) that results in a reduction of the fluorescent 
RSV count. We could circumvent this problem by correcting for 
the matrix effect using standard addition, but we foresee other 
possibilities in terms of improved receptor design. The very 
promising results for RSV, which is a difficult target, owing to its 
heterogeneity and variability in size and shape, suggest that the 
methodology may be generally applicable for viruses larger than 
ca. 80-100 nm. Certainly, the application of this method 
requires a sufficiently low background fluorescence of the 
sample matrix for the detection of the virus particles. However, 
this may be addressed by using fluorophores and spectral 
ranges that minimizes the autofluorescence of the sample. 
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